Save over 50% on Mulpleta from Europe - called Mulpleo in Europle
Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine
Manufacturer for all European Mulpleo:
Shionogi B.V.
Herengracht 464
1017CA
Amsterdam
The Netherlands
Information about Mulpleta (Lusutrombopag)
Mulpleta is a medication that contains lusutrombopag, a thrombopoietin receptor agonist used to increase platelet counts in patients with certain blood disorders. It is specifically designed to manage thrombocytopenia (low platelet counts) in adults.
Product Highlights
- Lusutrombopag mimics the action of thrombopoietin, stimulating the production of platelets from the bone marrow.
- Treatment of thrombocytopenia in patients with chronic liver disease who are scheduled to undergo a medical or surgical procedure.
Key Ingredient
Key Benefits
- Increases platelet counts, reducing the risk of bleeding during procedures.
- Provides an oral option for patients needing platelet support, offering convenience compared to injections.
- Can improve the quality of life for patients with chronic liver disease.
Direction of Use
- Take as directed by a healthcare professional, typically once daily.
- Can be taken with or without food, but it’s important to maintain consistent usage regarding meals.
Safety Concerns
- Frequently reported side effects may include headache, nausea, and fatigue.
- Rare but serious side effects can include thromboembolic events, particularly if platelet counts rise too quickly.
Avoid Mulpleta (Lusutrombopag) If
- You have a known hypersensitivity to lusutrombopag or any of its components.
- You have a history of thrombosis or thromboembolic disorders without proper medical supervision.
- You are currently receiving other treatments that may affect platelet levels without consulting your healthcare provider.
